Waters Corporation (WAT)

NYQ – Real Time Price. Currency in USD

352.21

+4.14 (1.19%)

At close: May 12, 2026, 4:00 PM EDT

345.41

-6.80 (-1.93%)

After-hours: May 12, 2026, 6:18 PM EDT

07.05.2026

WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues

Waters crushes Q1 2026 estimates as revenues surge 91.5%; newly acquired BD units top targets early, and 2026 guidance moves higher.

05.05.2026

Waters Corporation (WAT) Q1 2026 Earnings Call Transcript

05.05.2026

Waters raises annual profit forecast as biosciences unit drives growth

Lab equipment maker Waters raised its annual profit forecast on Tuesday after beating quarterly estimates, driven by robust demand for ‌drug development tools and the strong performance of its biosciences and diagnostics unit, acquired last year.

05.05.2026

Waters (WAT) Beats Q1 Earnings and Revenue Estimates

Waters (WAT) came out with quarterly earnings of $2.7 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.25 per share a year ago.

05.05.2026

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

First Quarter 2026 Highlights Total reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acquired businesses. Organic revenue grew 13% as reported and 11% in constant currency, exceeding the high end of the constant currency growth guidance range by 200 basis points – led by high-single-digit instrument growth and mid-teens chemistry growth within the Analytical Sciences Division.

29.04.2026

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

28.04.2026

Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Videos

No Data

There is no data to display

Press releases

05.05.2026

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

14.04.2026

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Delivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3 Achieves 10x improvement in absolute molar mass and extended sizing, without compromising resolution or analytical throughput.2 Reduces sample consumption by 30-50% and solvent use by approximately 40%.3 MILFORD, Mass., April 14, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio.

08.04.2026

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

FDA-approved BD Onclarity™ HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows. At-home self-collection reduces significant barriers for unscreened or under-screened individuals who make up approximately 60% of cervical cancer cases.3 Waters is establishing partnerships to enable broader nationwide access to the Onclarity™ HPV Self-Collection Kit for patients and prescribers to reduce cervical cancer risk.

18.03.2026

Waters Prices Offering of Senior Notes

MILFORD, Mass., March 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that it has priced an offering (the "Offering") of $3.5 billion aggregate principal amount of the following senior notes issued by its subsidiary, Augusta SpinCo Corporation ("Augusta"): $650 million aggregate principal amount of 4.321% Senior Notes due 2027 at the issue price of 100.000% of their principal amount; $600 million aggregate principal amount of 4.398% Senior Notes due 2029 at the issue price of 100.000% of their principal amount; $750 million aggregate principal amount of 4.656% Senior Notes due 2031 at the issue price of 100.000% of their principal amount; $750 million aggregate principal amount of 4.945% Senior Notes due 2033 at the issue price of 100.000% of their principal amount; and $750 million aggregate principal amount of 5.245% Senior Notes due 2036 at the issue price of 100.000% of their principal amount (collectively, the "Notes").

Waters Corporation (WAT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Waters Corporation (WAT)

WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues

Waters Corporation (WAT) Q1 2026 Earnings Call Transcript

Waters raises annual profit forecast as biosciences unit drives growth

Waters (WAT) Beats Q1 Earnings and Revenue Estimates

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Videos

No Data

Press releases

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Waters Prices Offering of Senior Notes

WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues

Waters Corporation (WAT) Q1 2026 Earnings Call Transcript

Waters raises annual profit forecast as biosciences unit drives growth

Waters (WAT) Beats Q1 Earnings and Revenue Estimates

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Videos

No Data

Press releases

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Waters Prices Offering of Senior Notes

Search stocks

Waters Corporation (WAT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Waters Corporation (WAT)

WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues

Waters Corporation (WAT) Q1 2026 Earnings Call Transcript

Waters raises annual profit forecast as biosciences unit drives growth

Waters (WAT) Beats Q1 Earnings and Revenue Estimates

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Videos

No Data

Press releases

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Waters Prices Offering of Senior Notes

WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues

Waters Corporation (WAT) Q1 2026 Earnings Call Transcript

Waters raises annual profit forecast as biosciences unit drives growth

Waters (WAT) Beats Q1 Earnings and Revenue Estimates

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Videos

No Data

Press releases

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Waters Prices Offering of Senior Notes